PRISM IMAGING – TBI

  • FDA approved (510K) to capture, quantify and analyze advanced structural and functional CNS imaging.
  • Allows for quantitative assessment of TBI and CTE.
    • Provides objective evidence of TBI
  • Can be utilized in acute and chronic TBI.
  • Can be used to optimize treatment planning as well as follow up to assess treatment response.
  • Can be used to diagnosis and follow-up treatment response in other neurocognitive and neurodegenerative disorders.

PRISM IMAGING – TBI